GlassScriptPhysician profile
Veronica Wong
NPI 1518248277
$7,919.19
in general payments reported to CMS, 2019-2025
24 companies · $1,597 in 2025
The $1,597 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $917 · 2020: $122 · 2021: $624 · 2022: $1,184 · 2023: $1,024 · 2024: $2,450 · 2025: $1,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,973 · Entertainment: $78.28 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,972.62 |
| Entertainment | $78.28 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,453.11 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Visioneering Technologies, INC. | $1,000.00 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $914.34 | 2019-2021 | |
| Alcon Vision LLC | $829.61 | 2019-2025 | Precision 1, Total30, Precision7 |
| Sun Pharmaceutical Industries INC. | $476.04 | 2019-2025 | |
| Glaukos Corporation | $361.29 | 2021-2025 | Idosetr, Photrexa Viscous and Photrexa |
| Tarsus Pharmaceuticals, INC. | $213.45 | 2024 | Xdemvy |
| Dompe US, INC. | $166.36 | 2022-2024 | Oxervate |
| Allergan, INC. | $162.60 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $125.81 | 2019 | |
| Coopervision INC. | $124.25 | 2019-2025 | Misight Contact Lens |
| Astellas Pharma US INC | $121.86 | 2025 | Izervay |
| Alexion Pharmaceuticals, INC. | $121.86 | 2025 | Ultomiris |
| Lkc Technologies, INC. | $119.20 | 2023 | |
| Harrow Eye, LLC | $113.00 | 2025 | Vevye |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $103.83 | 2024 | |
| Abbvie INC. | $96.56 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $89.17 | 2019-2025 | |
| Abb Con-Cise Optical Group LLC | $79.49 | 2019 | |
| Optos, INC. | $78.28 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec Ag | $58.20 | 2020 | |
| Genzyme Corporation | $48.74 | 2022 | |
| Oyster Point Pharma, INC. | $42.58 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.